CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial. (2017)
Attributed to:
Identification, roles and mechanisms of long non-coding RNAs in stem cells and metastasis in breast cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(17)30434-5
PubMed Identifier: 28592386
Publication URI: http://europepmc.org/abstract/MED/28592386
Type: Journal Article/Review
Volume: 18
Parent Publication: The Lancet. Oncology
Issue: 7
ISSN: 1470-2045